COMMUNIQUÉS West-GlobeNewswire

-
Avricore Grants Options
14/06/2025 -
SAFE - Lancement d’une réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions sous condition suspensive de la réalisation des opérations de regroupement d’actions
14/06/2025 -
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
13/06/2025 -
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
13/06/2025 -
MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse
13/06/2025 -
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
13/06/2025 -
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
13/06/2025 -
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
13/06/2025 -
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
13/06/2025 -
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
13/06/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2025
13/06/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13/06/2025 -
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
13/06/2025 -
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
13/06/2025 -
ORLADEYO® (berotralstat) Approved in Colombia
13/06/2025 -
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13/06/2025 -
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
13/06/2025
Pages